$9.17
+0.16 (+1.78%)
Open$9.14
Previous Close$9.01
Day High$9.27
Day Low$8.68
52W High$12.74
52W Low$6.47
Volume—
Avg Volume21.4K
Market Cap55.46M
P/E Ratio—
EPS$-3.51
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+444.6% upside
Current
$9.17
$9.17
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 31.36M | 12.59M | 12.91M |
| Net Income | -25,103,543 | -1,338,243 | -1,683,285 |
| Profit Margin | -80.1% | -10.6% | -13.0% |
| EBITDA | -28,976,223 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |